Pictet Asset Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.85M | Buy |
415,112
+71,153
| +21% | +$1M | 0.01% | 764 |
|
|
2025
Q1 | $5.06M | Buy |
343,959
+324,603
| +1,677% | +$4.78M | 0.01% | 799 |
|
|
2024
Q4 | $394K | Buy |
19,356
+2,806
| +17% | +$57.2K | ﹤0.01% | 1494 |
|
|
2024
Q3 | $482K | Buy |
16,550
+2,754
| +20% | +$80.2K | ﹤0.01% | 1343 |
|
|
2024
Q2 | $320K | Hold |
13,796
| – | – | ﹤0.01% | 1495 |
|
|
2024
Q1 | $283K | Sell |
13,796
-425,422
| -97% | -$8.73M | ﹤0.01% | 1572 |
|
|
2023
Q4 | $9.43M | Sell |
439,218
-150,281
| -25% | -$3.23M | 0.01% | 653 |
|
|
2023
Q3 | $12.2M | Buy |
+589,499
| New | +$12.2M | 0.02% | 585 |
|